Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Solid-phase/solution-phase combinatorial synthesis of neuroimmunophilin ligands.

M Rabinowitz1, P Seneci, T Rossi

  • 1Glaxo Wellcome, Inc., Research Triangle Park, NC 27709, USA. mhr20812@glaxowellcome.com

Bioorganic & Medicinal Chemistry Letters
|June 8, 2000
PubMed
Summary

A new synthesis method for neuroimmunophilin ligands was created. This approach efficiently produces many compounds for drug discovery using a novel purification technique.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trial.

ESMO gastrointestinal oncology·2026
Same author

Inhalation of nanoplastics in the mouse model: Tissue bio-distribution and effects on the olfactory system.

The Science of the total environment·2025
Same author

Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: subgroup analysis from CIRCULATE-Japan GALAXY.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Can wall shear-stress topology predict proliferative vitreoretinopathy localization following pars plana vitrectomy?

Journal of biomechanics·2023
Same author

Self-compassion is associated with optimum self-care behaviour, medical outcomes and psychological well-being in a cross-sectional sample of adults with diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2017
Same author

A Toe Flexion NIRS assisted Test for Rapid Assessment of Foot Perfusion in Peripheral Arterial Disease: Feasibility, Validity, and Diagnostic Accuracy.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2017

Area of Science:

  • Medicinal Chemistry
  • Organic Synthesis
  • Neuroscience

Background:

  • Neuroimmunophilins are crucial targets in neurological research.
  • Developing efficient synthesis strategies for novel ligands is essential for drug discovery.
  • GPI 1046 serves as a key structural motif for neuroimmunophilin ligands.

Purpose of the Study:

  • To develop a novel solid-phase/solution-phase synthesis strategy for neuroimmunophilin ligands.
  • To enable the production of multi-milligram quantities of discrete compounds for biological assays.
  • To create a scalable and high-throughput method for ligand synthesis and purification.

Main Methods:

  • A combined solid-phase esterification and solution-phase pyruvic amide formation strategy was employed.

Related Experiment Videos

  • The protocol was validated through the synthesis of a library of 880 discrete compounds.
  • A novel aqueous liquid/ice extraction system was utilized for high-throughput purification.
  • Main Results:

    • The developed strategy successfully produced multi-milligram quantities of neuroimmunophilin ligands.
    • The synthesis protocol was applied to generate a library of 880 distinct compounds.
    • The novel extractive purification method proved effective for high-throughput compound isolation.

    Conclusions:

    • The novel solid-phase/solution-phase strategy offers an efficient route to neuroimmunophilin ligands.
    • The high-throughput purification system facilitates rapid compound isolation for screening.
    • This approach supports the advancement of drug discovery for neurological targets.